Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2023 | 3 |
2024 | 2 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Unexpected and Rare Sites of Metastasis in Oncologic Patients.
J Clin Med. 2023 Oct 10;12(20):6447. doi: 10.3390/jcm12206447.
J Clin Med. 2023.
PMID: 37892585
Free PMC article.
Tolerated Re-Challenge of Immunotherapy in a Patient with ICI Associated Myocarditis: A Case Report and Literature Review.
Shalata W, Attal ZG, Shhadi R, Abu Salman A, Abu Jama A, Shalata S, Halumi K, Yakobson A.
Shalata W, et al. Among authors: shalata s.
Medicina (Kaunas). 2023 Nov 3;59(11):1946. doi: 10.3390/medicina59111946.
Medicina (Kaunas). 2023.
PMID: 38003995
Free PMC article.
Review.
Item in Clipboard
Perimyocarditis Associated with Immune Checkpoint Inhibitors: A Case Report and Review of the Literature.
Shalata W, Steckbeck R, Abu Salman A, Abu Saleh O, Abu Jama A, Attal ZG, Shalata S, Alnsasra H, Yakobson A.
Shalata W, et al. Among authors: shalata s.
Medicina (Kaunas). 2024 Jan 28;60(2):224. doi: 10.3390/medicina60020224.
Medicina (Kaunas). 2024.
PMID: 38399513
Free PMC article.
Review.
Item in Clipboard
Cemiplimab as First Line Therapy in Advanced Penile Squamous Cell Carcinoma: A Real-World Experience.
Rouvinov K, Mazor G, Kozlener E, Meirovitz A, Shrem NS, Abu Saleh O, Shalata S, Yakobson A, Shalata W.
Rouvinov K, et al. Among authors: shalata s.
J Pers Med. 2023 Nov 20;13(11):1623. doi: 10.3390/jpm13111623.
J Pers Med. 2023.
PMID: 38003938
Free PMC article.
Item in Clipboard
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB Status.
Shalata W, Maimon Rabinovich N, Agbarya A, Yakobson A, Dudnik Y, Abu Jama A, Cohen AY, Shalata S, Abu Hamed A, Ilan Ber T, Machluf O, Shoham Levin G, Meirovitz A.
Shalata W, et al. Among authors: shalata s.
Cancers (Basel). 2024 May 10;16(10):1825. doi: 10.3390/cancers16101825.
Cancers (Basel). 2024.
PMID: 38791905
Free PMC article.
Item in Clipboard
Cite
Cite